logo
logo

Microsure Secures €38 Million To Advance Its Microsurgical Robot, Musa-3

Oct 04, 2023•almost 2 years ago

Amount Raised

€38 Million

EindhovenMedical DeviceMedicalBiotechnologyHealth Care

Investors

KineoKreske Nickelsen

Description

Microsure, innovation leader in robot-assisted microsurgery, announced today the successful closing of its Series B2 investment round securing €38 million in development capital. With this funding, Microsure will finalize the development of its newest microsurgical robot MUSA-3 for clinical studies, followed by FDA clearance in the USA and CE-mark in Europe. As part of this financing round, Kreske Nickelsen from new investor kineo will join the supervisory board, further strengthening Microsure's governance.

Company Information

Company

Microsure

Location

Eindhoven, North Brabant, Netherlands

About

We deliver and continuously improve a high precision microsurgical robot. Supermicrosurgeons work at the forefront of their field. They must be able to maintain maximum focus for the time required and operate down to sub-millimeter levels. With our microsurgical robot, microsurgeons can operate even smaller anatomical structures in a more comfortable setting. Together with them, we work towards our vision to leave no patient in need of microsurgery untreated. MUSA-2 is the first CE certified microsurgical robot. It has been used during various clinical studies, and feedback from professionals on its in-clinic performance has played a key role in the development of MUSA-3. MUSA offers among others scaled movements, tremor filtration and use of own instruments which improves the surgeon’s precision even further.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People